Celanese (CE) Reports Q4 Earnings: What Key Metrics Have to Say

For the quarter ended December 2024, Celanese (CE) reported revenue of $2.37 billion, down 7.8% over the same period last year. EPS came in at $1.45, compared to $2.24 in the year-ago quarter.The reported revenue represents a surprise of +3.03% over the Zacks Consensus Estimate of $2.3 billion. With the consensus EPS estimate being $1.20, the EPS surprise was +20.83%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Celanese performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Net Sales- Acetyl Chain: $1.11 billion compared to the $1.06 billion average estimate based on five analysts. The reported number represents a change of -6% year over year. Net Sales- Inter segment eliminations: -$21 million compared to the -$18.72 million average estimate based on five analysts. The reported number represents a change of +16.7% year over year. Net Sales- Engineered Materials: $1.28 billion versus $1.27 billion estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -8.9% change. Operating EBITDA- Acetyl Chain: $316 million versus the four-analyst average estimate of $303.73 million. Operating EBITDA- Other Activities: -$69 million compared to the -$94.95 million average estimate based on four analysts. Operating EBITDA- Engineered Materials: $270 million versus the four-analyst average estimate of $243.96 million. View all Key Company Metrics for Celanese here>>>Shares of Celanese have returned -6.3% over the past month versus the Zacks S&P 500 composite's +4.7% change. The stock currently has a Zacks Rank #5 (Strong Sell), indicating that it could underperform the broader market in the near term.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Celanese Corporation (CE): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks